DUBLIN–(BUSINESS WIRE)–The “Regulatory Report: The Kanavape Ruling’s Impact On EU Harmonization Of CBD” report has been added to ResearchAndMarkets.com’s offering.
Since the publishing of the Kanavape decision in November 2020, some EU member states are still non-compliant with it, and a number of member states still view as illegal CBD-containing vape products, hemp flowers, and extraction from flowers.
This report aims to analyze the developments of the European CBD regulatory landscape almost one and a half years after the crucial ruling of the Kanavape case.
Specifically, the analysis focuses on the compliance by EU member states with the decision of the Court of Justice of the European Union (CJEU) in different policy areas and the direct impact on European Commission (EC) policy decisions.
Key Topics Covered:
1 Executive Summary
2 Introduction
3 Kanavape Case
4 Developments Toward Harmonization
5 The Future Of Kanavape and EU Harmonization On CBD
6 Member States’ Compliance With The Kanavape Ruling
For more information about this report visit https://www.researchandmarkets.com/r/fbqtqr
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
This post was originally published on this site
0 thoughts on “EU Regulatory Report 2022: The Kanavape Ruling’s Impact on EU Harmonization of CBD – ResearchAndMarkets.com”
Argentina CBD and Cannabis Market Regulations Report 2022 – ResearchAndMarkets.com
United States Medical Cannabis Product State-by-State Regulatory Report 2022 – ResearchAndMarkets.com